Implant Sciences Products Selected as Best of Breed; Now on Permanent Display at Secure Strategy Group Washington D.C. Showroom
WILMINGTON, MA--(Marketwire - June 2, 2010) - Implant Sciences Corporation (
Secure Strategy Group is a strategic advisory firm that backs and builds best of breed growth companies in the security technology field. The firm identifies technologies that address key growth areas in the homeland security market. These products and technologies are displayed at Secure Strategy Group's newly launched Washington D.C. showroom, the SSG Solutions Center. Secure Strategy Group has been a consultant to Implant Sciences since February 2009.
The SSG Solutions Center enables buyers, including government agencies, prime contractors, and systems integrators, to "touch and feel" Implant's products. The SSG Solutions Center is located at the Center for Innovative Technology (CIT), a world-class office complex located less than five minutes from Dulles Airport, right in the heart of Washington, D.C.'s technology corridor.
Scott Greiper, founder and President of SSG, stated, "We've selected Implant Sciences and its products for showcase because Implant's portable, highly effective and cost-efficient QS-H150 directly addresses one of the fastest growing sectors in homeland security."
Robert Liscouski, Implant Sciences board member and SSG partner and Head of Business Development and Strategy, added, "Being part of the permanent display at the SSG Solutions Center will help Implant Sciences reach key purchasers and opinion leaders in Washington. We hope this visibility will lead to sales growth while decreasing associated operational expenses for Implant."
"We are pleased and honored to be selected by Secure Strategy Group as a best of breed solutions provider. This is a very efficient way for our products to gain further traction and continue to enhance our revenue outlook," stated Implant Sciences CEO, Glenn Bolduc.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company's website at [ www.implantsciences.com ].
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the U.S. government or by other law enforcement agencies or commercial consumers of security products; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.